Yeast frataxin Iron Oxidative stress yfh1 ggc1 Mössbauer Mitochondrion Yeast cells deficient in the yeast frataxin homolog (Yfh1p) accumulate iron in their mitochondria. Whether this iron is toxic, however, remains unclear. We showed that large excesses of iron in the growth medium did not inhibit growth and did not decrease cell viability. Increasing the ratio of mitochondrial iron-to-Yfh1p by decreasing the steady-state level of Yfh1p to less than 100 molecules per cell had very few deleterious effects on cell physiology, even though the mitochondrial iron concentration greatly exceeded the iron-binding capacity of Yfh1p in these conditions. Mössbauer spectroscopy and FPLC analyses of whole mitochondria or of isolated mitochondrial matrices showed that the chemical and biochemical forms of the accumulated iron in mitochondria of mutant yeast strains (Δyfh1, Δggc1 and Δssq1) displayed a nearly identical distribution. This was also the case for Δggc1 cells, in which Yfh1p was overproduced. In these mitochondria, most of the iron was insoluble, and the ratio of soluble-to-insoluble iron did not change when the amount of Yfh1p was increased up to 4500 molecules per cell. Our results do not privilege the hypothesis of Yfh1p being an iron storage protein in vivo.
Introduction
Friedreich's ataxia is the most common hereditary recessive ataxia. The gene responsible for this neurodegenerative disease was cloned in 1996 [1] . The corresponding protein (frataxin) was found to be a small, highly conserved mitochondrial protein. Similar crystal or NMR structures have been resolved for the human, yeast and bacterial homologs of this protein [2] .
It is now generally accepted that frataxin (Yfh1p in yeast) is one of the components of the mitochondrial [Fe-S] cluster machinery, acting either as an iron donor, or more generally as a chaperone interacting in an iron-dependent manner with the desulfurase/scaffold proteins involved in [Fe-S] assembly [3, 4] . However, the precise role of frataxin is more difficult to define than that of other components of the [Fe-S] cluster machinery, maybe because frataxin is a multifunctional protein (for a recent review, see [5] ). Indeed, the lack of frataxin results in direct or indirect defects in many pathways other than [Fe-S] biogenesis, including heme synthesis [6, 7] , oxidative stress defense [8, 9] , apoptosis [10] and mitochondrial iron homeostasis [11] . This paper focuses on the relationship between Yfh1p and iron. The yeast frataxin (Yfh1p) can bind iron in vitro in the monomeric [12] , trimeric [13] or oligomeric/multimeric form [14] . The biochemical and structural aspects of iron-binding by frataxin have been studied extensively (reviewed in [2] ). Yfh1p monomers can selfassemble in vitro in an iron-dependent manner to yield a macromolecular complex with physical features consistent with a role in iron storage [15] . The assembly of Yfh1p in vitro is a stepwise process that requires the presence of Fe(II). Fe(II) is converted into Fe(III) during the oligomerization process, yielding ferritin-like particles of 24 or 48 subunits. Yfh1p monomers are arranged into trimers within these particles, which contain up to 2400 iron atoms [13] [14] [15] [16] . Frataxin has been compared to ferritin, despite major structural differences, since both proteins can convert redox-active iron into an inert mineral through ferroxidation activity [14] . These findings led several authors to suggest that frataxin not only promotes the biogenesis of ironcontaining proteins (through monomeric or small oligomeric forms of the protein), but also detoxifies surplus iron in the mitochondria (through the formation of ferritin-like frataxin particles), thereby mediating a major antioxidant mechanism [17, 18] . Biochimica et Biophysica Acta 1802 (2010 [531] [532] [533] [534] [535] [536] [537] [538] It remains unclear, however, whether the iron storage properties of frataxin demonstrated in vitro play a role in, or are required for, in vivo function. In a recent study, Gakh et al. [18] showed that Yfh1p oligomerization in vivo is induced by iron, heat stress and overproduction of the monomer. However, they did not show iron storage in Yfh1p multimers in vivo. We also previously observed that overexpression of YFH1 resulted in an increased level of Yfh1p oligomerization in vivo, but the shift in Yfh1p distribution after gel filtration was not accompanied by a shift in iron distribution, suggesting that iron was not stored in the multimers [19] . In the present study, we investigate this issue further by analyzing the physico-chemical properties of iron accumulated in the mitochondria of different yeast strains in the presence of various amounts of Yfh1p. We conclude that Yfh1p did not store iron in vivo under our experimental conditions.
Material and methods

Yeast strains and growth conditions
The strains used in this study were YPH499 (wild-type; MATa ura3-52 lys2-801 ade2-101 trp1-Δ63 his3-Δ200 leu2-Δ1 cyh2), YPH499Δyfh1 (Δyfh1; Δyfh1::TRP1), BY4741 (wild-type; MATa his3D1 leu2D0 met15D0 ura3D0), BY4741Δggc1 (Δggc1; Δggc1:: kanMX4), BY4741Δggc1-YFH1 (Δggc1 transformed with the multicopy plasmid pRS423, expressing YFH1 under the control of its native promoter, thus resulting in the overexpression of YFH1 in this strain) and BY4741Δssq1 (Δssq1; Δssq1::kanMX4). To construct the strain with YFH1 under estradiol control (ERyfh1), the starting strain YPH499 was subjected to a promoter swap by transformation with a His3MX-pGAL1 cassette, thereby placing YFH1 under GAL1 control. In this strain, the GAL4 gene was replaced with KanMX (Δgal4:: KanMX), and transformants selected for geneticin (G418) resistance and grown in anaerobic conditions. Next, the pGEV2-LEU2 centromeric plasmid was introduced by anaerobic transformation in the presence of 5 µM estradiol [20, 21] . In this plasmid, the beta estradiol inducible activator GAL4-ER-VP16 is expressed from a low level constitutive MRP7 promoter [20, 21] . Subsequently cultures were maintained aerobically in the presence or absence of various concentrations of estradiol. The cells grew robustly at 5 µM estradiol but poorly in the absence of estradiol. Unless otherwise stated, cells were grown aerobically in defined medium (6.7 g/l yeast nitrogen base without amino acids, iron or copper, and containing 0.1% glucose, 2% raffinose and 0.8 g/l amino acids). The defined media were supplemented with 5 µM CuSO 4 and with various amounts of iron, in the form of ferric citrate.
Mössbauer spectroscopy
57 Fe Mössbauer experiments were operated using a 50 mCi source of 57Co(Rh) (AREVA). The spectra were recorded either on a zero-field Mössbauer spectrometer equipped with a custom-made cryostat or on a strong-field Mössbauer spectrometer equipped with an Oxford Instruments Spectromag 4000 cryostat containing an 8 T split-pair superconducting magnet. Both spectrometers were operated in a constant acceleration mode in transmission geometry. The 14.4 keV g-rays were detected by means of a proportional counter and the spectra were recorded on a 512 multichannel analyzer working in the multiscaling mode. The temperature of the sample was measured with a Pt resistor. The system was calibrated with a metallic iron foil absorber at room temperature, and all velocity scales and isomer shifts are referred to the iron standard. Analysis of the data was performed with the program WMOSS (WEB Research, Edina, MN).
Iron uptake and enzyme assays
Iron uptake was measured in microtiter plates, after incubating cells for 30 min in minimum medium with 1 µM 55 Fe(II)-ascorbate, as previously described [22] . The specific activity of iron was 29,600 MBq/mg. The in-gel aconitase assay was performed as previously described [23] .
Immunochemical reagents and western blot analysis
The anti-Yfh1 rabbit antibody was generated and checked as previously described [24] . Samples were incubated in Laemmli sample buffer for 5 min at 100°C. They were then separated by SDS-PAGE in a 13% polyacrylamide gel and the protein bands were electrotransferred onto a Hybond nitrocellulose membrane (Amersham Pharmacia Biotech, Piscataway, USA). Primary antibody binding was detected, after incubation with peroxidase-conjugated secondary antibody, with chemiluminescent substrate (Supersignal West from Pierce, Rockford, USA). Signals were quantified using ImageJ software (http://rsb.info.nih.gov/ij/). For the oxyblots, carbonylated proteins were detected and analyzed following derivatization of protein carbonyl groups with 2,4-dinitrophenylhydrazine (DNPH) (Oxyblot kit, Abcys, Paris, France). The primary antibody used for western blot analysis was raised against dinitrophenylhydrazone (DNP).
Cell fractionation
Mitochondrial and cytosolic fractions were isolated after treatment of cells with zymolyase, followed by lysis of the protoplasts in 0.6 M sorbitol (buffered with TRIS 50 mM, pH 7.8), in the presence of protease inhibitors (Protease inhibitor cocktail, P8215, Sigma) as described previously [25] . The purity of the mitochondrial fraction was estimated by the activity of cytochrome oxidase, as previously described [25] . Submitochondrial fractionation was carried out as previously described [26] , by hypotonic shock followed by sonication (1 min, 3 times) in 10 mM HEPES buffer (without EDTA; pH 7.2). Total, soluble and insoluble iron content in whole mitochondria and in mitochondrial matrices was measured by scintillation counting in the corresponding fractions.
Fast protein liquid chromatography (FPLC)
The distribution of iron-containing proteins from the mitochondrial matrix was analyzed by size-exclusion chromatography. Mitochondria (from cells grown with 1 µM 55 Fe(III)-citrate) were lyzed in hypotonic buffer (HEPES 10 mM, pH 7) and sonicated for 30 s before being centrifuged at 25,000 g for 30 min. Supernatants (0.5 ml, 20 mg protein/ml) were loaded onto a Superdex 200 10/ 300 GL column (GE Healthcare) and proteins were eluted at a flow rate of 0.2 ml/min with 50 mM HEPES and 140 mM NaCl, pH 8.0, using the FPLC system ÄKTA purifier UPC 10 (GE Healthcare). Fractions (0.2 ml) were collected and the radioactivity of each fraction was counted in a microplate scintillation counter (MicoBeta TriLux). The column was calibrated with a gel filtration standard (Bio-Rad). Fractions were concentrated and equal volumes of each fraction were analyzed by SDS-PAGE and western blotting.
Other
Low-temperature absorption spectra (− 191°C) of whole cells were recorded as previously described [27, 28] .
Results
Toxicity of mitochondrial iron in Δyfh1 cells
The amount of iron accumulated in the mitochondria of Yfh1p-depleted cells is directly proportional to the iron concentration in the growth medium [29] . In the model assuming a major role played by Yfh1p in mitochondrial iron storage [15] , the disruption of YFH1 would increase the concentration of unbound iron in the mitochondrial matrix, explaining the increased sensitivity of cells to oxidative stress. Thus, mitochondrial iron would be toxic in Δyfh1 cells, due to the inability of these cells to store this iron in the proper form [13] . This model is frequently referred to in the literature; however, to our knowledge there is no study clearly showing a toxic effect of iron in Yfh1p-depleted cells. We tested the effect of increasing the concentration of iron in the medium (in the range of 1 to 2500 µM) on the growth of wild-type and Δyfh1 cells, and on cell viability (Fig. 1) . Our results showed that the toxicity of iron was surprisingly low in Δyfh1 cells: excess iron even improved the growth of Δyfh1 cells, an effect that depended on the carbon source used for growth. When raffinose was used, iron (up to a concentration of 250 µM) clearly stimulated the growth of Δyfh1 cells, but not of wild-type cells (Fig. 1A) . This stimulating effect of iron on the growth of Δyfh1 cells was less marked when glucose was used as the carbon source. However, iron added in large excess clearly had a weaker toxic effect in Δyfh1 cells than in wild-type cells (Fig. 1B) . The effect of iron on the viability of stationary phase Δyfh1 cells was stronger than the effect of iron on cell growth (Fig. 1C) . After 7 days of growth, more than 70% of the wild-type cells were still viable, whatever the iron concentration added to the medium (0-2,500 µM; data not shown). In the same conditions, nearly 100% of Δyfh1 cells were not viable when no iron was added in the medium, while about 40% of the cells remained viable at the highest iron concentrations (250-2500 µM; Fig. 10C ). In contrast, copper added to the growth medium was much more toxic to Δyfh1 cells than to wild-type cells: the growth of Δyfh1 cells started to be inhibited at concentrations of CuSO 4 of 25 µM and above, whereas the growth of wild-type cells remained unaffected below CuSO 4 concentrations of 250 µM (data not shown). Thus, iron is less toxic to Yfh1p-depleted cells than would be expected if iron accumulated in a redoxactive form. We previously showed that most of the iron accumulated in the mitochondria of Δyfh1 cells was present in an amorphous precipitated form, unavailable for heme synthesis [6] .
Physiological effects of increasing the iron-to-Yfh1p ratio by decreasing the steady-state expression of YFH1
We studied the effect of strongly decreasing the production of Yfh1p in a strain in which transcription of the YFH1 gene was controlled by the concentration of estradiol in the growth medium (strain ERyfh1). There are several advantages of this system over systems with YFH1 under the control of the GAL1 or gal1* (compromised GAL1) promoters [30] . First, repression of YFH1 transcription does not require changing the carbon source from galactose to glucose, which leads to catabolic repression and interferes with mitochondrial metabolism. Second, in the estradiol system, YFH1 transcription is not simply on or off, as it is in the galactose system. Rather, different concentrations of estradiol in the medium allow different steady-state rates of transcription to be obtained [20, 21] .
Quantitative immunoblotting (using purified Yfh1p as a standard) allowed us to estimate the number of Yfh1p molecules per cell for each condition tested, as previously described [19] . Fig. 2 shows the amount of Yfh1p per cell for the ERyfh1 strain, as a function of estradiol concentration in the medium. The amount of Yfh1p ranged from nearly 0 to about 1300 molecules per cell ( Fig. 2) . At a concentration of 2.5 nM estradiol in the medium, the amount of Yfh1p was lower than 100 molecules per cell, reaching about 1300 molecules per cell at a concentration of 10 nM estradiol, similar to the level of Yfh1p found in wild-type cells ( Fig. 2 ; [19] ). The phenotype of cells containing 100 to 1300 molecules Yfh1p per cell is shown in Fig. 3 . Wild-type levels of aconitase activity were recovered from cells showing the lowest amounts of Yfh1p (Fig. 3A) , whereas cytochrome synthesis was recovered progressively, with wild-type levels being reached at levels of Yfh1p similar to those found in wildtype cells (Fig. 3B) . Thus, as we previously showed for the overexpression of YFH1 [19] , decreasing YFH1 expression in vivo can also differentiate between phenotypes related to [Fe-S] cluster synthesis and those related to heme synthesis. Mitochondrial iron was also recovered at nearly wild-type levels in cells showing the lowest levels of YFH1 expression (Fig. 3C ). This observation is consistent with a tight relationship between the biogenesis of mitochondrial iron-sulfur proteins and the regulation of iron uptake/distribution [31] . Additionally, the amount of oxidatively modified (carbonylated) proteins also returned to nearly wild-type levels in cells with the lowest levels of YFH1 expression (Fig. 3D) .
In a previous study, we showed that the number of "free iron" atoms is between 100 and 500 times greater than the number of Yfh1p molecules in the mitochondrial compartment of wild-type cells [19] . In the present study, we generated yeast cells with a diminished steady-state level of Yfh1p giving rise to a mitochondrial iron-toYfh1p ratio more than 10 times higher than wild-type. This resulted in very few deleterious effects on cell physiology (Fig. 3) . Other previous studies have shown that Yfh1p cellular levels can be significantly reduced before the adverse effects on cell growth are detected, even in the presence of excess intracellular iron [30, 32] . Thus, if Yfh1p were an iron storage protein protecting cells against iron-induced oxidative damage, these findings suggest that this detoxification by Yfh1p must be a highly efficient process, with very low amounts of Yfh1p (less than 100 molecules per cell) detoxifying large amounts of "free iron" (1000-5000 times more iron than frataxin). However, such a process seems unlikely, given that the highest estimated iron-to-Yfh1p ratio in a Fe-Yfh1 multimeric complex gives only 50 atoms of iron per Yfh1 subunit [14, 15, 33] . An alternative explanation of these data would imply that Yfh1 behaves more "dynamically" than ferritin, binding iron transiently to deliver it with very high efficiency to aconitase. We investigated these questions further, comparing different yeast strains that accumulate iron in the mitochondria in the presence of different amounts of Yfh1p.
Solubility of iron in the mitochondria of different yeast strains
We compared the soluble and insoluble iron contents of mitochondria isolated from various yeast strains with different ironto-Yfh1p ratios. The soluble iron pool is defined as the pool of iron in the mitochondrial matrix that remains in solution after centrifugation at 100,000 g for 30 min, after disruption of the mitochondria by a hypotonic shock followed by sonication (see Section 2) . For this study, we compared mitochondria isolated from a wild-type, a Δyfh1 mutant, a Δggc1 mutant, and a Δggc1 mutant overexpressing YFH1 on a multicopy plasmid (Δggc1-YFH1). Cells deleted for the GGC1 gene accumulate iron in their mitochondria [34, 35] , as do Δyfh1 cells. The level of Yfh1p in these different strains was estimated by western blot (Fig. 4) . There were about 1000 Yfh1p molecules per cell in the wildtype, 800 in the Δggc1 mutant and 4500 in the Δggc1 mutant overexpressing the YFH1 gene. Overexpressing YFH1 in Δggc1 cells did not significantly change the amount of total iron accumulated in the cells and did not improve the respiration or growth of the cells, but decreased the amount of oxidized proteins in the mitochondria, as evidenced by oxyblots (data not shown). We purified the mitochondria from these various strains grown with 1 µM 55 Fe(III)-citrate, and determined the amount of iron present in a soluble and insoluble form (Fig. 5) . Wild-type mitochondria contained about 20 nmol iron per mg protein, more than half of which was present in a soluble form (Fig. 5A) . Mitochondria from the Δyfh1, Δggc1 and Δggc1-YFH1 mutant strains contained 70-100 nmol iron per mg protein, most of which was insoluble (Fig. 5A) . The small soluble fraction of iron was probably overestimated, since disruption of the mitochondria was achieved by sonication, which could lead to the release of some iron from the insoluble pool into solution or pseudo-solution (small micelles of iron which would not be recovered in the centrifugation pellets). The amount of soluble iron in the mitochondrial matrix of the Δggc1 mutant was similar in cells overexpressing YFH1 (Fig. 5A ). The ratio of insoluble iron to soluble iron in the mitochondria was similar for the three mutants (15-to 17-fold higher than in wild-type mitochondria), and did not depend on the amount of Yfh1p (Fig. 5B) . Thus, mutations leading to iron accumulation in the mitochondria (yfh1 or ggc1) also lead to iron precipitation in the matrix, regardless of the amount of Yfh1p. Our results thus suggest that the protective effect against protein oxidation in Δggc1 cells overproducing Yfh1p did not result from direct iron chelation by Yfh1p. These findings were consistent with results obtained from experiments described below (Sections 3.4 and 3.5).
Mössbauer spectroscopy of whole mitochondria
We further analyzed the form of iron accumulated in mitochondria isolated from mutant strains, grown with 10 µM 57 Fe(III)-citrate, using Mössbauer spectroscopy. For this study, we included an additional strain, Δssq1, which is also known to accumulate mitochondrial iron [36] . Consistent with previous observations [6] , the 4.2 K Mössbauer spectrum of Δyfh1 mitochondria (Fig. 6 ) displayed one slightly asymmetric quadrupole doublet with δ = 0.52 (1) mm/s, ΔE Q = 0.63(2) mm/s and Γ = 0.52/0.50(2) mm/s, typical of a high-spin ferric iron bound to oxygen/nitrogen in an octahedral arrangement. As discussed previously [6] , the line-width broadening and the Fe/P ratio of 1/2.9 [37] may be due to polydisperse nanoparticles of ferric phosphate. Spectra recorded in applied magnetic fields up to 7 T reflected a distribution of hyperfine fields, similar to those observed by Lindahl et al. in their study of mitochondria from Yah1p-and Atm1p-depleted cells [38, 39] . The central doublet of high field spectra (Fig. 6 ) corresponded to about 1/ 4 of the spectral area, indicating that the magnetic moments were oriented in the direction of the applied field. The variable field spectra were best fitted using a near rectangular distribution of hyperfine fields in the range 0 T b B hf b 40 T (Fig. 7) . At both 4.2 K and 78 K, the same spectra were obtained for mitochondria isolated from the Δssq1, Δggc1, and Δggc1-YFH1 mutants (Fig. 8) . Similarly, these strains showed the same hyperfine field distribution in the presence of an applied magnetic field. Similar values for δ and ΔE Q have previously been reported for bacterial Ferritin cores [40, 41] . Unlike eukaryote ferritins, which display magnetically-split spectra up to relatively high temperatures (T B ∼ 30 K), bacterial ferritins show paramagnetic transitions around 3 K. The lack of a magnetically ordered phase above temperatures of a few Kelvins have been associated with a lower degree of crystallinity and a higher phosphate content-hence longer Fe-Fe distances-of bacterial ferritin cores [42, 43] . We recorded spectra of mitochondria from the yeast mutants at a temperature of 1.6 K. At this low temperature we did not see any magnetic splitting, but observed a broadening of the main doublet, suggesting the onset of a paramagnetic transition. This, and the high phosphate content of the mitochondria, suggest that the degree of crystallinity of the accumulated iron must be even lower than in bacterial ferritins. Moreover, bacterioferritins display a narrow range of hyperfine fields around 42 T [40, 41] , whereas all the mutant mitochondria we studied showed a uniform distribution of B hf in the range of 0 to 40 T. These results are consistent with a model in which the accumulated iron is not in the form of ferric cores of definite size encapsulated in protein envelopes, but rather in the form of amorphous aggregates of ferric phosphate randomly distributed in the mitochondria. Iron was under the same chemical form in all the mutants studied even in the mutant overexpressing YFH1. Mitochondria isolated from the Δggc1-YFH1 mutant yielded exactly the same Mössbauer spectrum as the other mutants, with similar intensity. Thus, increasing the amount of Yfh1p did not result in any measurable change in the amount or chemical form of the iron accumulated in the mitochondria.
Analysis of soluble mitochondrial iron by FPLC
Most of the iron accumulated in the mitochondria of the mutant strains was insoluble (Fig. 5) . It is therefore possible that small differences in the soluble mitochondrial iron pool of the different strains were difficult to detect by Mössbauer spectroscopy of whole mitochondria. We thus further studied the composition of mitochondrial iron in the various strains by analyzing the matrix-soluble fractions by gel filtration, separating out the iron-binding proteins in the matrix. Wild-type, Δyfh1, Δggc1 and Δggc1-YFH1 cells were grown with 1 µM 55 Fe(III)-citrate. Soluble mitochondrial fractions (matrix) were purified and analyzed by FPLC on a gel filtration column after centrifugation at 25,000 g for 30 min. The elution patterns of iron for the various strains are shown in Fig. 9A . In the four strains analyzed, the soluble mitochondrial iron eluted in three main peaks, of N670 kDa, 50 kDa and 15 kDa. A fourth peak of about 4 kDa was present in the matrix of wild-type and Δyfh1 cells, but not in the matrix of Δggc1 or Δggc1-YFH1 cells (Fig. 9A) . The first peak (N670 kDa) probably corresponds to small particles/aggregates of iron that were not completely removed by centrifugation and to iron that was non-specifically associated with high molecular weight protein complexes. The last peak (4 kDa) probably corresponds to iron chelated by organic compounds. The two other peaks (50 kDa and 15 kDa) probably correspond to iron specifically bound to ironbinding protein(s), these peaks being resolved further by subsequent anion-exchange chromatography (MonoQ; data not shown). For two samples of mitochondrial matrix (Δggc1 and Δggc1-YFH1), fractions of various molecular masses were analyzed by immunoblotting for Yfh1p (Fig. 9B) . Consistent with our findings from a previous study [19] , overexpressing YFH1 resulted in a higher level of frataxin oligomerization in the matrix (Fig. 9B ). However, although the level of frataxin and the extent of its oligomerization differed between the mitochondrial matrixes from Δggc1 and Δggc1-YFH1 cells, the pattern of iron elution from the gel filtration column was qualitatively and quantitatively identical for these two samples (Fig. 9A) . We also detected peaks at 50 kDa and 15 kDa, although with different intensities, in the eluate from the Δyfh1 mitochondrial matrix sample (Fig. 9A) . Thus, none of these peaks seemed to be due to iron bound to Yfh1p.
Discussion
In yeast, the lack of the frataxin homolog Yfh1p results in a marked accumulation of iron in the mitochondria [44, 45] . This iron is generally considered to be the cause of the hypersensitivity to oxidative stress in frataxin-deficient cells (reviewed in [9] ), which thus assumes that it accumulates in a redox-active form. However, many different yeast mutants, most of which with impaired [Fe-S] cluster assembly, accumulate large amounts of iron in their mitochondria, as observed for Δyfh1 cells, despite these other mutants expressing a functional frataxin [46] . Additionally, these mutant strains show differing levels of sensitivity to oxidative stress. The lack of frataxin is thus not the specific and the only cause of mitochondrial iron accumulation and, conversely, mitochondrial iron accumulation cannot be the cause of all the phenotypes observed in frataxindeficient cells. Therefore, to investigate a potential link between hypersensitivity to oxidative stress and mitochondrial iron accumulation in Δyfh1 cells, the phenotypes of other mutants, which also accumulate mitochondrial iron but produce a functional Yfh1p, also need to be taken into account. In one insightful study by Yang et al. [47] , the authors compared the forms of iron between mitochondria from various yeast strains, based on assessing the ability of iron to displace manganese in Sod2p ("Sod2p-reactive iron"). They found that iron was Sod2p-reactive in some strains (Δmtm1, Δssq1 and Δgrx5), but not in Δyfh1 [47] . This result can be interpreted as evidence that Yfh1p is required for inactivation of Sod2 by metal replacement [47] , but may also be due to iron being less reactive in Δyfh1 mitochondria than in the mitochondria of other mutants. The study by Yang et al. [47] opened up the possibility that iron may accumulate in slightly different forms in the mitochondria of different mutants. Our data do not exclude this possibility. Indeed, our analyses of the soluble pools of mitochondrial iron, as analyzed by gel filtration, showed quantitative differences between the Δyfh1 and Δggc1 strains (more iron in the 50 kDa peak obtained for Δggc1 than for Δyfh1 mitochondria, for example). However, both mutants showed peaks of iron at the same position (50 kDa and 15 kDa), showing that Yfh1p was not involved in the generation of these peaks. The same can be concluded for the comparison between the Δggc1 and the Δggc1-YFH1 strains: for these strains, the elution profiles of soluble iron were quantitatively and qualitatively undistinguishable, despite Yfh1p being overproduced (five times the wild-type level) in one strain and not in the other. Moreover, Mössbauer spectroscopic analysis of whole mitochondria from Δyfh1, Δssq1, Δggc1 and Δggc1-YFH1 cells did not reveal any difference in the forms of iron accumulated between mitochondria of these different strains. We previously showed by the same technique that iron accumulated in Δyfh1 mitochondria as amorphous nanoparticles of ferric phosphate, unavailable biologically [6] . In this study, we found the same to be true for other iron-accumulating mutants, Δssq1 and Δggc1, regardless of the amount of Yfh1p present. Similar findings have also been described for other yeast mutants accumulating iron in the mitochondria, yah1 and atm1 [38, 39] . Thus, although we cannot exclude the possibility that small, undetectable differences exist between strains, which cannot be detected by the methods employed, iron accumulates mostly in the same precipitated amorphous form in the mitochondria of different mutants, irrespective of Yfh1p abundance. It is possible that our experimental conditions were not optimal for the observation of ferritin-like frataxin particles. Indeed, oligomerization of Yfh1p has been shown to occur under particular conditions in vivo, for example in cells that overexpress monomeric Yfh1p, or that are exposed to heat stress or conditions that increase iron influx into the mitochondria [18] . We have also noted that increasing the level of YFH1 expression results in an increase in the level of Yfh1p oligomerization ( [19] and present work). However, there is no evidence demonstrating that higher levels of iron are associated with the formation of larger Yfh1p oligomers in vivo, despite studies showing that Yfh1p assembly requires the presence of Fe 2+ and is dependent on iron concentration in vitro [14, 18, 32] . Rather, we found that a shift in the level of Yfh1p oligomerization in vivo was not accompanied by a shift in the distribution of soluble iron ( [19] and present work). Moreover, we overexpressed Yfh1p monomers in cells that accumulate iron in their mitochondria (Δggc1), these two conditions (overexpression and increased iron influx) having been shown previously to induce Yfh1p oligomerization [18] , but we did not detect any trace of ferritin-like frataxin particles using various experimental methods. The possibility remains, however, that the iron accumulated in Δggc1 mitochondria is not accessible for binding by Yfh1p, as we don't know if iron accumulation/precipitation in the Δggc1 mutant occurs downstream or upstream to a putative ironbinding step by Yfh1p (which could result in a form of iron no longer suitable for binding by Yfh1p, i.e. precipitated ferric phosphate). This question is illustrated in Fig. 10 .
In another approach, we investigated whether we could provide evidence of Yfh1p acting as an iron storage protein in vivo through quantitative evaluation. Frataxin has been functionally compared to ferritin [14, 33] , but ferritin is abundant in mammals, whereas frataxin is not abundant in yeast [19] . In wild-type cells, Yfh1p is present at a concentration of about 1000 molecules per cell in most growth conditions [19] . Even at this low concentration, Yfh1p is in large excess relative to the cell requirements. Indeed, Yfh1p levels can be significantly reduced without any adverse effect on cell growth [30, 32] . We observed that less than 100 molecules of Yfh1p per cell were sufficient to restore aconitase activity and to significantly reduce the amount of oxidatively modified protein in the mitochondria (compared to frataxin-deficient cells). At these levels of Yfh1p, the number of soluble iron atoms in the mitochondrial matrix was between 1000 and 5000 times greater than the number of Yfh1p molecules. This greatly exceeds the iron-binding capacity of Yfh1p, the iron-to-Yfh1p ratio in the multimeric iron storage form of Yfh1p generally being considered not to exceed 50 [14, 15] . As we noted in a previous study [19] , the fact that Yfh1p can fulfill the cell requirements at very low concentration is consistent with a catalytic role played by this protein-probably involving its transient association with iron.
These various observations suggest that Yfh1p does not play a major role, if any, in mitochondrial iron storage. Our conclusion is consistent with the findings of Aloria et al. [32] , who showed that a mutant Yfh1p defective in iron-induced oligomerization in vitro was able to functionally replace the wild-type protein, even when produced at very low levels. Previous observations that the expression of human mitochondrial ferritin in Δyfh1 yeast cells attenuates the deleterious phenotypes of this mutant seem also to be inconsistent with our findings [48, 49] . This interesting result does not mean, however, that ferritin functionally replaced frataxin in these experiments. It is possible that expression of ferritin in other ironaccumulating mutants that have normal levels of Yfh1p would also improve cell viability. Iron accumulation in mutant mitochondria results in iron precipitation, yielding biologically unavailable ferric particles, with a paradoxically smaller pool of soluble, available iron than in wild-type mitochondria. Thus, although the mutant mitochondria are full of iron, the cells behave as if they were iron-deprived (for example, inducing the iron regulon) [50] . Iron chelation by ferritin in these mutant mitochondria may make more iron available for biological processes, regardless of the function of Yfh1p, potentially explaining the beneficial effect of ferritin expression. It is also possible that the soluble iron pool in mutant mitochondria, although containing a smaller amount of iron than in wild-type mitochondria, has a higher level of redox activity, which would also explain the positive effect of iron chelation by ferritin. Finally, if ferritin exerted its beneficial effects on the physiology of Δyfh1 cells by replacing an iron storage function of Yfh1p, we would expect Yfh1p overproduction to have beneficial effects in cells that overaccumulate iron in their mitochondria for reasons other than the lack of frataxin. However, we did not find this to be the case in Δggc1 cells.
An important question thus remains: what mechanism underlies the sensitivity of Δyfh1 cells to oxidative stress? Most of the accumulated iron in Δyfh1 mitochondria is precipitated, oxidized and amorphous. This iron is therefore probably no more redox-active than it is bioavailable. However, it is possible that the soluble iron, although present in a smaller amount in Δyfh1 than in wild-type mitochondria, could be more bioavailable in Δyfh1 mitochondria. Additionally, even if Yfh1p does not store large amounts of iron in vivo, its interaction with iron may still play an essential role in its function. There does not seem to be any doubt, however, that the lack of frataxin also leads, at least in part, to iron-independent sensitivity to oxidative stress. In human, frataxin-deficient cells are unable to properly recruit antioxidant defense mechanisms [8] , probably due to impaired nuclear translocation of the Nrf2 transcription factor [51] . In yeast, preventing iron accumulation in the mitochondria of Δyfh1 cells (by excess zinc in the medium or by iron chelation) does not decrease the sensitivity of cells to oxidative stress [24, 52] . Conversely, some suppressor strains, derived from Δyfh1 mutants by spontaneous mutation, still accumulate iron in their mitochondria but show increased resistance to oxidative stress [6] . Finally, frataxin-deficient Candida albicans cells (ΔCayfh1/Δ) are much more sensitive to oxidative stress than S. cerevisae Δyfh1 cells, but accumulate much less iron in the mitochondria [22] . The link between iron accumulation and oxidative stress sensitivity in frataxin-deficient cells (and in other iron-accumulating mutants) is not straightforward, and clearly requires further investigation. ) and is chelated by one or several unknown compound(s) (FeX1 and FeX2), before being used for heme synthesis and [Fe-S] cluster assembly. Yfh1p, which is required for efficient iron use in the mitochondria, might be involved in different steps of these processes (as an ironbinding protein, and/or an iron storage protein and/or a chaperone protein). GTP, which is imported into the mitochondria via the GTP/GDP carrier Ggc1p, is also required for [Fe-S] assembly. Proper [Fe-S] cluster assembly is required to avoid massive iron import in the mitochondria (through a mechanism that remains to elucidate, which we schematized in the form of a negative retro-control of [Fe-S] clusters on mitochondrial iron import). B. Δyfh1. In the absence of Yfh1p, [Fe-S] cluster assembly is impaired, leading to increased iron import in the mitochondria. This iron precipitates with phosphates, maybe after an oxidation step. Whether this iron precipitates immediately after its uptake or after subsequent step(s) of binding is not known. C. Δggc1-YFH1. The lack of GTP results in [Fe-S] cluster assembly impairment, leading to increased iron import in the mitochondria. Overproduction of Yfh1p does not prevent precipitation of this iron in the form of ferric phosphate. If iron is available for binding by Yfh1p from the first step of its uptake, Yfh1p is not an iron storage protein. If precipitation of iron occurred upstream to the binding step by Yfh1p, there is a possibility that the precipitated iron is no more available for binding by Yfh1p (dotted arrows).
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